For the latest case updates, including breaking news about proposed resolution and upcoming trial, see this website: www.EpiPenClassAction.com
Mylan Settlement Update
February 28, 2022: According to Co-Lead Counsel and Managing Partner of Keller Rohrback Lynn Sarko, “Today’s announcement of our $264 million-dollar settlement with Mylan brings the total recovery to EpiPen class members to $609 million. We urge consumers and third-party payors who paid for EpiPens to visit EpiPenClassAction.com to learn more about today’s settlement.”
Pfizer Settlement Update
On November 17, 2021, the Court entered an order giving final approval to the settlement between Plaintiffs and the Pfizer Defendants. This order and other key case documents are available on the Settlement Administrator’s website EpiPenClassAction.com (see Case Documents tab). Inquiries relating to the settlement can be directed to the Settlement Administrator, A.B. Data, at (877) 221-7632.
CONTACT US:
For more information about this case, please email us, call us, or fill out the secure form below.